McInnes IB, Asahina A, Coates LC, Landewe R, et al. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet 2023;401:25-37.
PMID: 36493791